The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126819623 12681962 3 F 20160829 20160824 20160902 EXP US-SA-2016SA155267 AVENTIS ANDERSON B.J., PETERSON L.L., SYSTEMIC CAPILLARY LEAK SYNDROME IN A PATIENT RECEIVING ADJUVANT OXALIPLATIN FOR LOCALLY ADVANCED COLON CANCER, J. ONCOL. PHARM. PRACT.. 2016 OCT 01; 22(5):725-728. 63.00 YR A M Y 0.00000 20160902 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126819623 12681962 1 PS OXALIPLATIN. OXALIPLATIN 1 Unknown Y UNKNOWN 21759 /cycle
126819623 12681962 2 SS OXALIPLATIN. OXALIPLATIN 1 Unknown Y UNKNOWN 21759 /cycle
126819623 12681962 3 C 5-FU FLUOROURACIL 1 Unknown UNKNOWN 0 /cycle
126819623 12681962 4 C 5-FU FLUOROURACIL 1 Unknown UNKNOWN 0 /cycle
126819623 12681962 5 C LEUCOVORIN. LEUCOVORIN 1 Unknown UNKNOWN 0 /cycle
126819623 12681962 6 C LEUCOVORIN. LEUCOVORIN 1 Unknown UNKNOWN 0 /cycle
126819623 12681962 7 C ONDANSETRON ONDANSETRON 1 Unknown 0
126819623 12681962 8 C DEXAMETHASONE. DEXAMETHASONE 1 Unknown U 0
126819623 12681962 9 C GUAIFENESIN. GUAIFENESIN 1 Unknown 0
126819623 12681962 10 C LITHIUM. LITHIUM 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126819623 12681962 1 Colorectal cancer stage III
126819623 12681962 2 Colorectal cancer stage III
126819623 12681962 3 Colorectal cancer stage III
126819623 12681962 4 Colorectal cancer stage III
126819623 12681962 5 Colorectal cancer stage III
126819623 12681962 6 Colorectal cancer stage III
126819623 12681962 8 Premedication
126819623 12681962 9 Productive cough
126819623 12681962 10 Schizoaffective disorder

Outcome of event

Event ID CASEID OUTC COD
126819623 12681962 HO
126819623 12681962 LT
126819623 12681962 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126819623 12681962 Acute kidney injury
126819623 12681962 Acute respiratory distress syndrome
126819623 12681962 Anuria
126819623 12681962 Blood pressure systolic increased
126819623 12681962 Capillary leak syndrome
126819623 12681962 Cardiac output decreased
126819623 12681962 Crepitations
126819623 12681962 Cyanosis
126819623 12681962 Dilatation ventricular
126819623 12681962 Dizziness
126819623 12681962 Dyspnoea
126819623 12681962 Foaming at mouth
126819623 12681962 Haemoconcentration
126819623 12681962 Hyperdynamic left ventricle
126819623 12681962 Hyperhidrosis
126819623 12681962 Hyperkalaemia
126819623 12681962 Hypoalbuminaemia
126819623 12681962 Hypotension
126819623 12681962 Hypoxia
126819623 12681962 Lung infiltration
126819623 12681962 Metabolic acidosis
126819623 12681962 Nephrogenic diabetes insipidus
126819623 12681962 Oedema peripheral
126819623 12681962 Polyuria
126819623 12681962 Pulmonary oedema
126819623 12681962 Tachypnoea

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found